On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Richard J. Gralla

ResearcherPublications, citations & collaboration network

Richard J. Gralla is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Richard J. Gralla have?

ScholarIQindexed works

Richard J. Gralla has 373 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Richard J. Gralla have?

ScholarIQcitation count

Richard J. Gralla has 22,631 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Richard J. Gralla?

ScholarIQh-index

Richard J. Gralla has an h-index of 72 in OpenAlex.

What is the i10-index of Richard J. Gralla?

ScholarIQi10-index

Richard J. Gralla has an i10-index of 174 in OpenAlex.

What is the ORCID of Richard J. Gralla?

ScholarIQorcid

The ORCID for Richard J. Gralla is on the source record.

What is the OpenAlex record for Richard J. Gralla?

ScholarIQopenalex

The OpenAlex for Richard J. Gralla is on the source record.

What are the most-cited papers on Richard J. Gralla?

ScholarIQmost cited works
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, K. Mattson, Richard J. Gralla, Mark Allen O’Rourke, Nathan Levitan, Laurent Gressot, Mark Vincent, Ronald L. Burkes, Susan Coughlin, Yong Kim, J. Bérille
Journal of Clinical Oncology. 20002,193 Citations
Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
Chee Khoon Lee, Chris Brown, Richard J. Gralla, Vera Hirsh, Sumitra Thongprasert, Chun‐Ming Tsai, Eng Huat Tan, Jcm Ho, D. Chu, Adel Zaatar, Jemela Anne Osorio Sanchez, Vu Van Vu, Joseph S. K. Au, Akira Inoue, Siow Ming Lee, Val Gebski, James Chih‐Hsin Yang
JNCI Journal of the National Cancer Institute. 2013514 CitationsOPEN ACCESS
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
Paul J. Hesketh, Antônio Rossi, Giada Rizzi, Marco Palmas, Anna Alyasova, Igor Bondarenko, Alla Lisyanskaya, Richard J. Gralla
Annals of Oncology. 2014224 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account